Skip to main content
. Author manuscript; available in PMC: 2014 Apr 21.
Published in final edited form as: J Investig Med. 2010 Dec;58(8):945–949. doi: 10.231/JIM.0b013e3181fb7ca7

Table 3.

Cross tabulation of year 2002 samples based on C-LDL-C and D-LDL-C at clinically meaningful LDL-C treatment goals. Numbers along the diagonal of the table (in bold) indicate where the measures agree. Numbers in the off-diagonal cells indicate some level of disagreement.

C-LDL-C D-LDL-C Treatment Goal (mg/dl)
Treatment
Goal (mg/dl)
<70 70 – 100 100 – 130 130 – 160 ≥ 160 Total
<70 60 60 0 1 0 121
70 – 100 11 182 64 0 0 257
100 – 130 7 21 158 40 0 226
130 – 160 0 0 21 101 5 127
≥ 160 0 1 1 14 60 76
Total 78 264 244 156 65 807

Kappa Statistic: 0.5982 (0.5559, 0.6405)

Generalized McNemar Test: p < 0.001

HHS Vulnerability Disclosure